Thursday, October 26, 2017 10:15 PM ET
Significant Insider purchase Extends the buy Trend of Last 90 Days in Shares of Radius Health (RDUS)
There was a substantial insider buy in Radius Health shares today as revealed in a filing with the SEC. One insider — Biotech Growth N V, 10% Owner — acquired 50,000 shares in the company having a net market value of approximately $1,642,415. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been buys resulting in the purchase of 469,100 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 519,100 shares and have averaged 129,775 shares per transaction over this time period.
During the last 90 days, the number of insider buy/sell trades at Radius Health is higher than the 265-company peer group average. Bio Therapeutic Drugs peer group saw 318 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Radius Health insiders was also higher. Within the peer group there were 10,302,908 shares purchased and 12,281,272 shares sold with company insiders selling 6,221 shares on average.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data sourced to create and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.